{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:32:39Z","timestamp":1786984359871,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","amjmedsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.amjms.2017.02.008","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T14:46:08Z","timestamp":1488465968000},"page":"335-338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Secondary Hyperparathyroidism in Heart Failure"],"prefix":"10.1016","volume":"354","author":[{"given":"Mohamed S.","family":"Morsy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight A.","family":"Dishmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadish","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl T.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2017.02.008_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10557-012-6378-0","article-title":"Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism","volume":"27","author":"Rutledge","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.amjms.2017.02.008_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/jamacardio.2016.1878","article-title":"Mineralocorticoid receptor antagonists in the management of heart failure and resistant hypertension: a review","volume":"1","author":"Flatt","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjms.2017.02.008_bib3","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N Engl J Med"},{"issue":"suppl 5","key":"10.1016\/j.amjms.2017.02.008_bib4","doi-asserted-by":"crossref","first-page":"V2","DOI":"10.1093\/ndt\/gfh1049","article-title":"The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes","volume":"19","author":"H\u00f6rl","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjms.2017.02.008_bib5","first-page":"219","article-title":"Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia","volume":"14","author":"Massry","year":"1994","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.amjms.2017.02.008_bib6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.surg.2007.06.015","article-title":"Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism","volume":"142","author":"Costa-Hong","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.amjms.2017.02.008_bib7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11255-010-9897-2","article-title":"Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease","volume":"44","author":"Lishmanov","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.amjms.2017.02.008_bib8","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/ajt.12425","article-title":"Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation","volume":"13","author":"Perrin","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.amjms.2017.02.008_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ctr.12666","article-title":"Bone fractures and lumbar mineral density after renal transplantation. A long-term cross-sectional study","volume":"30","author":"Jim\u00e9nez","year":"2016","journal-title":"Clin Transplant"},{"key":"10.1016\/j.amjms.2017.02.008_bib10","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1161\/ATVBAHA.113.303062","article-title":"Plasma-parathyroid hormone is associated with subclinical and clinical atherosclerotic disease in 2 community-based cohorts","volume":"34","author":"Hagstr\u00f6m","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjms.2017.02.008_bib11","doi-asserted-by":"crossref","first-page":"H2023","DOI":"10.1152\/ajpheart.00477.2004","article-title":"Loss of bone minerals and strength in rats with aldosteronism","volume":"287","author":"Chhokar","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.amjms.2017.02.008_bib12","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.CIR.0000155621.10213.06","article-title":"Hyperparathyroidism and the calcium paradox of aldosteronism","volume":"111","author":"Chhokar","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2017.02.008_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00000441-200609000-00003","article-title":"Secondary hyperparathyroidism and hypovitaminosis D in African-Americans with decompensated heart failure","volume":"332","author":"LaGuardia","year":"2006","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjms.2017.02.008_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00000441-200601000-00009","article-title":"Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure","volume":"331","author":"Khouzam","year":"2006","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjms.2017.02.008_bib15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MAJ.0b013e318167b0bd","article-title":"Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure","volume":"335","author":"Alsafwah","year":"2008","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjms.2017.02.008_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2011.05.005","article-title":"Parathyroid hormone, vitamin D, renal dysfunction and cardiovascular disease: dependent or independent risk factors?","volume":"162","author":"Anderson","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjms.2017.02.008_bib17","doi-asserted-by":"crossref","first-page":"e001278","DOI":"10.1161\/JAHA.114.001278","article-title":"Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis","volume":"3","author":"Bansal","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjms.2017.02.008_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.amjcard.2011.08.039","article-title":"Relation of serum parathyroid hormone level to severity of heart failure","volume":"109","author":"Altay","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjms.2017.02.008_bib19","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/CIRCHEARTFAILURE.114.001272","article-title":"Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease","volume":"7","author":"Wannamethee","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjms.2017.02.008_bib20","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jacc.2011.03.069","article-title":"Vitamin D, parathyroid hormone and cardiovascular events among older adults","volume":"58","author":"Kestenbaum","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2017.02.008_bib21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s40618-016-0561-2","article-title":"Secondary hyperparathyroidism prevalence and prognostic role in elderly males with heart failure","volume":"40","author":"Loncar","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.amjms.2017.02.008_bib22","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/eurjhf\/hfr016","article-title":"Parathyroid hormone and vitamin D\u2014markers for cardiovascular and all cause mortality in heart failure","volume":"13","author":"Schierbeck","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjms.2017.02.008_bib23","doi-asserted-by":"crossref","first-page":"e0135427","DOI":"10.1371\/journal.pone.0135427","article-title":"1,25-Dihydroxyvitamin D to PTH(1-84) ratios strongly predict cardiovascular death in heart failure","volume":"10","author":"Gruson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.amjms.2017.02.008_bib24","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2017.02.008_bib25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/eurjhf\/hfs002","article-title":"Bone mass loss in chronic heart failure is associated with secondary hyperparathyroidism and has prognostic significance","volume":"14","author":"Terrovitis","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjms.2017.02.008_bib26","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1161\/CIRCULATIONAHA.108.784009","article-title":"Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16,294 patients","volume":"118","author":"van Diepen","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2017.02.008_bib27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2265.1996.701521.x","article-title":"Risk factors for secondary hyperparathyroidism in a nursing home population","volume":"44","author":"Stein","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.amjms.2017.02.008_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jacc.2008.03.039","article-title":"Fracture risk in men with congestive heart failure. Risk reduction with spironolactone","volume":"52","author":"Carbone","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2017.02.008_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/MAJ.0b013e3182058864","article-title":"Supplemental vitamin D and calcium in the management of African-Americans with heart failure having hypovitaminosis D","volume":"341","author":"Zia","year":"2011","journal-title":"Am J Med Sci"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962917301234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962917301234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T07:55:07Z","timestamp":1574927707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962917301234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0002962917301234"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2017.02.008","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary Hyperparathyroidism in Heart Failure","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2017.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Southern Society for Clinical Investigation. Published by All rights reserved.","name":"copyright","label":"Copyright"}]}}